Insilico Medicine recognized by Endeavor Venture Group & Mount Sinai Health System with Showcase AI and Biotech Innovation Award
2024-11-27
(Press-News.org)
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, is proud to be recognized for the impact on the future of drug discovery and development, as a distinguished honoree of the Showcase AI and Biotech Innovation Award on November 13, 2024, at the Fifth Endeavor Venture Group & Mount Sinai Health System Healthcare AI and Technology Investor Summit. Michelle Chen, Ph.D., Chief Business Officer of Insilico Medicine, received the award on behalf of the company.
Delivered with the joint efforts of Endeavor Venture Group and Mount Sinai Health system, the hybrid event gathered seasoned venture capitalists and over 175 health tech companies including Google, IBM, Northwell Health and Bayer, focusing on integrating cutting-edge technologies into hospitals, biopharma, and enterprises.
In 2016, Insilico first described the concept of using generative AI for the design of novel molecules in a peer-reviewed journal, which laid the foundation for the commercially available Pharma.AI platform. Since then, Insilico keeps integrating technical breakthroughs into Pharma.AI platform, which is currently a generative AI-powered solution spanning across biology, chemistry, medicine development and science research. Powered by Pharma.AI, Insilico has nominated 20 preclinical candidates in its comprehensive portfolio of over 30 assets since 2021 and has received IND clearance for 10 molecules.
In early 2024, Insilico published a Nature Biotechnology paper presenting the entire R&D journey from AI algorithms to Phase II clinical trials of ISM001-055, the company's lead drug pipeline with AI-discovered target and AI-designed structure. Following that, Insilico has recently announced positive preliminary results from a Phase IIa trial (NCT05938920), where ISM001-055 showed favorable safety and tolerability across all dose levels, as well as dose-dependent response in forced vital capacity (FVC), after only 12 weeks of dosage.
About Insilico Medicine
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.
www.insilico.com
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-11-27
Lugano, Switzerland, 27 November 2024 – The ESMO Asia Congress 2024 is the annual event dedicated to multidisciplinary oncology in the Asian region. It will feature a broad spectrum of topics in cancer research, including novel treatment modalities, in-depth discussions on the management of specific cancer types, pan-Asian trials and subgroup analyses of cutting-edge studies relevant for the patients in the area. Data will be presented and discussed by leading experts from across Asia and beyond. The congress will be held onsite in Singapore from 6-8 December, with no virtual option available.
Programme highlights
Subgroup ...
2024-11-27
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS). These two conditions exacerbate each other, creating a vicious cycle that increases the risk of cardiovascular diseases. Understanding the pathophysiological relationship between OSA and MetS is crucial for developing effective prevention and treatment strategies. This review explores current knowledge on the connection between OSA and MetS and discusses the progress in treatment ...
2024-11-27
Chimpanzees are known for their remarkable intelligence and use of tools, but could their cultures also evolve over time like human cultures? A new, multidisciplinary study led by the University of Zurich suggests that some of their most advanced behaviors may have been passed down and refined through generations.
In recent decades, scientists have clearly demonstrated that chimpanzees, like humans, pass on complex cultures such as tool use from generation to generation. But human culture has become vastly more sophisticated, ...
2024-11-27
By providing flexibility services to renewable energy systems, consumers can both help in balancing power grids and receive financial benefits. Hosna Khajeh’s doctoral dissertation from the University of Vaasa, Finland, introduces new methods that enable the efficient utilisation of energy users’ flexibility resources in distribution and transmission networks.
As the use of weather-dependent renewable energy sources increases, power systems need to become more flexible to guarantee energy supply at all times. One of the necessary steps for the future is making it possible for consumers to support both national and local power grids with ...
2024-11-27
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.
A team of researchers from the University of Bristol analysing automated insulin delivery data from people with Type 1 Diabetes (T1D) discovered that unexpected patterns in insulin needs are just as common as well-established ones.
The study, published today in JMIRx Med aimed to identify patterns in changes of insulin needs and to analyse how frequently these occur in people with T1D who use the OpenAPS, a state-of-the-art, ...
2024-11-27
Solid oxide cells (SOCs), including solid oxide fuel cells (SOFCs) and solid oxide electrolysis cells (SOECs), are among the most promising energy conversion technologies due to their high efficiency and fuel flexibility. However, the high-temperature sintering required for their manufacture often leads to undesirable reactions at the electrolyte and electrode interface, degrading cell performance. A thin, dense ceria-based barrier layer, typically composed of gadolinium-doped ceria (GDC), is widely used to prevent these reactions. Achieving sufficient densification ...
2024-11-27
The Ministry of Science and ICT (MSIT), headed by Minister Yoo Sang-im, held the launch ceremony for the "AI Safety Institute" (AISI) on Wednesday, November 27, at the Pangyo Global R&D Center.
At the "AI Seoul Summit"last May, leaders from 10 countries recognized safety as a key component of responsible AI innovation and emphasized the importance of establishing AI safety institutes and fostering global collaboration for safe AI. President Yoon Suk Yeol also expressed his commitment, stating, "We will work towards establishing an AI safety institute in Korea and actively participate ...
2024-11-27
Exposure to air pollutants (PM2.5 and PM10) is associated with an increased risk of persistent long-COVID symptoms, partly due to its impact on the severity of the acute infection. This is the main conclusion of a study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by “la Caixa” Foundation, in collaboration with the Germans Trias i Pujol Research Institute (IGTP), and published in Environmental Health Perspectives.
Long-COVID is a heterogeneous condition in which symptoms like fatigue, breathlessness, and cognitive issues persist for months after ...
2024-11-27
CHICAGO – Soccer heading may cause more damage to the brain than previously thought, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).
Heading is a widely used technique in soccer where the players control the direction of the ball by hitting it with their head. In recent years, research has been done that suggests a link between repeated head impacts and neurodegenerative diseases, such as chronic traumatic encephalopathy (CTE).
“The potential effects of repeated head impacts in sport are ...
2024-11-27
A new study has linked distinct neural and behavioral characteristics in autism spectrum disorder to a simple computational principle. Centered on the “dynamic range” of neurons, which reflects how gradually or sharply they respond to input, the study suggests that individuals with autism spectrum disorder have an increased dynamic range in their neuronal response, resulting in a more detailed but slower response to changes. This research defies previous descriptions of ASD as a “broken cog in the machine” and provides a deeper, richer account of the computational basis of ASD.
[Hebrew University of Jerusalem]– Researchers Dr. Yuval Hart and Oded ...
LAST 30 PRESS RELEASES:
[Press-News.org] Insilico Medicine recognized by Endeavor Venture Group & Mount Sinai Health System with Showcase AI and Biotech Innovation Award
